Concepedia

Emily Cheney

EC

Statistics

Publications

6

Citations

1.1K

H-Index

6

Active since

2018

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Dana-Farber/Harvard Cancer Center

AC Camargo Hospital

Harvard University

Emily Cheney is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

2018–2021

6

Publications

6

PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer

Constantia Pantelidou, Olmo Sonzogni, Mateus de Oliveira Taveira et al. · Cancer Discovery · 2019 · 720 citations · Full text

Medicine, Immunology, Oncology +17

Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer

Anita K. Mehta, Emily Cheney, Christina Hartl et al. · Nature Cancer · 2020 · 259 citations · Full text

Medicine, Immunology, Oncology +16

Dysregulation in Actin Cytoskeletal Organization Drives Increased Stiffness and Migratory Persistence in Polyploidal Giant Cancer Cells

Botai Xuan, Deepraj Ghosh, Emily Cheney et al. · Scientific Reports · 2018 · 79 citations · Full text

Medicine, Cell Biology, Oncology +17

Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer

Christina Hartl, Adrian Bertschi, Regina Bou-Puerto et al. · Journal for ImmunoTherapy of Cancer · 2019 · 36 citations · Full text

Medicine, Immunology, Oncology +17

860 Targeting immunosuppressive macrophages overcomes PARP-inhibitor resistance in BRCA1-associated triple-negative breast cancer

Anita K. Mehta, Emily Cheney, Christina Hartl et al. · 2020 · 25 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 6